
Darbatitor 60mcg Injection
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Darbepoetin alfa (60mcg)
Overview Darbatitor 60mcg Injection
Epoetin alfa 60mcg injection treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. This medication requires careful administration due to potential serious adverse reactions; expert medical supervision is crucial. Strict adherence to physician instructions is essential. Administration occurs under healthcare professional guidance. Frequently reported side effects encompass abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral edema. Report symptoms of severe hypertension—intense headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests will monitor electrolyte levels (like potassium), hemoglobin, and blood cell counts. Discontinue use and seek medical advice for shortness of breath or skin rash. Prior to treatment, disclose any history of heart disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or planning pregnancy/breastfeeding individuals should consult their physician for safety assessment.
Uses of Darbatitor 60mcg Injection
Managing Anemia in Chronic Kidney Disease and Cancer Chemotherapy
Major Benefits of Darbatitor 60mcg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Darbatitor 60mcg Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbatitor 60mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Darbatitor 60mcg Injection works:
Darbepoetin alfa 60 mcg injection is a medication that boosts red blood cell production. This erythropoiesis-stimulating agent acts on the bone marrow, the blood cell-producing tissue within bones, to increase red blood cell creation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darbatitor 60mcg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Darbatitor 60mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Darbatitor 60mcg Injection while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Darbatitor 60mcg Injection.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, the 60mcg Darbatitor injection presents a safe treatment option; no dosage modification is necessary.
LiverCAUTION
Patients with hepatic impairment should use Darbatitor 60mcg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Darbatitor 60mcg Injection :
Should you forget a Darbatitor 60mcg Injection, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.
Facts to Know About Darbatitor 60mcg Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Erythropoietin-stimulating drug |
